Jef: to the first part; you're looking at an apple (DMX) and an orange (PVLS). Provalis is regarded by the british press as a pharma failure, reinventing itself as a drug distributor, although it does still have some activities in the pharma development area. That area, I have no idea about.
Neither make money. I believe that DMX will show a profit first of the two.
Valuation is a pretty relative thing, in the market. PVLS is getting a bit of good press and is moving up, altho' it hit 52 week low last week.
I hold DMX as a long term investment, willing to trade a bit of my total holding. I have been adding in the past weeks.
I bought PVLS as a more short term thing. The english and irish like to call these stocks a good punt, as in a good wager/gamble/bet. To summarize, I'd take a punt on PVLS and I'd bet my retirement on DMX.
As to your other question -
Some Pennsaid RX's were probably filled, but if so, it would have been under similar rules to those of Canada, where you can get a not-yet approved drug, in a special medical situation. I'm being longwinded - what I'm trying to say, is, you can get Pennsaid in Canada for some time now, even though they mislaid the application file at Health Canada. I'd imagine the same is true of the UK. Phew! its very late evening here.
aside- Does anyone have any TA comments to post, this baby seems to be having a hard time getting through the 7 dollar mark. I recollect that the previous post re resistance levels was :
$6, then $7.25 and then $8.50-9.00. Anyone? Don. |
